- Home
- MRM vs BCLI Comparison
MRM vs BCLI Comparison
Compare MRM & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRM
- BCLI
- Stock Information
- Founded
- MRM 2000
- BCLI 2000
- Country
- MRM Japan
- BCLI United States
- Employees
- MRM N/A
- BCLI N/A
- Industry
- MRM Other Consumer Services
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MRM Consumer Discretionary
- BCLI Health Care
- Exchange
- MRM Nasdaq
- BCLI Nasdaq
- Market Cap
- MRM 10.7M
- BCLI 9.8M
- IPO Year
- MRM 2020
- BCLI N/A
- Fundamental
- Price
- MRM $1.42
- BCLI $1.17
- Analyst Decision
- MRM
- BCLI
- Analyst Count
- MRM 0
- BCLI 0
- Target Price
- MRM N/A
- BCLI N/A
- AVG Volume (30 Days)
- MRM 21.6K
- BCLI 395.1K
- Earning Date
- MRM 05-20-2025
- BCLI 08-13-2025
- Dividend Yield
- MRM N/A
- BCLI N/A
- EPS Growth
- MRM 27.65
- BCLI N/A
- EPS
- MRM 0.18
- BCLI N/A
- Revenue
- MRM $52,786,758.00
- BCLI N/A
- Revenue This Year
- MRM N/A
- BCLI N/A
- Revenue Next Year
- MRM N/A
- BCLI N/A
- P/E Ratio
- MRM $7.80
- BCLI N/A
- Revenue Growth
- MRM 21.55
- BCLI N/A
- 52 Week Low
- MRM $0.34
- BCLI $0.72
- 52 Week High
- MRM $8.39
- BCLI $6.30
- Technical
- Relative Strength Index (RSI)
- MRM 51.75
- BCLI 48.71
- Support Level
- MRM $1.33
- BCLI $1.17
- Resistance Level
- MRM $1.45
- BCLI $1.32
- Average True Range (ATR)
- MRM 0.08
- BCLI 0.09
- MACD
- MRM -0.01
- BCLI 0.00
- Stochastic Oscillator
- MRM 50.00
- BCLI 50.00
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.